C1QTNF6 and neoplasm: Therapeutically, a nanoparticle-based system co-delivering siRNA against CTRP6 and gemcitabine significantly enhanced ferroptotic markers and suppressed tumor growth, an effect reversed by ferroptosis inhibition [20].